These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10914104)

  • 1. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s.
    Freeman AJ; Zekry A; Whybin LR; Harvey CE; van Beek IA; de Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G; Lloyd AR
    Med J Aust; 2000 Jun; 172(12):588-91. PubMed ID: 10914104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
    Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
    J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in hepatitis C virus genotype in injecting drug users.
    Aitken C; McCaw R; Jardine D; Bowden S; Higgs P; Nguyen O; Crofts N; Hellard M
    J Med Virol; 2004 Dec; 74(4):543-5. PubMed ID: 15484265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
    Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.
    Matheï C; Wollants E; Verbeeck J; Van Ranst M; Robaeys G; Van Damme P; Buntinx F
    Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):514-22. PubMed ID: 16133411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus genotypes in Australia.
    McCaw R; Moaven L; Locarnini SA; Bowden DS
    J Viral Hepat; 1997 Sep; 4(5):351-7. PubMed ID: 9310934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
    Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
    J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil.
    Silva MB; Andrade TM; Silva LK; Rodart IF; Lopes GB; Carmo TM; Zarife MA; Dourado I; Reis MG
    Mem Inst Oswaldo Cruz; 2010 May; 105(3):299-303. PubMed ID: 20512243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
    Bowden S; McCaw R; White PA; Crofts N; Aitken CK
    J Viral Hepat; 2005 May; 12(3):322-4. PubMed ID: 15850474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities.
    Majid A; Holmes R; Desselberger U; Simmonds P; McKee TA
    J Med Virol; 1995 May; 46(1):48-51. PubMed ID: 7542693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.
    Silva FQ; Santos FJA; Andrade AP; Pacheco SDB; Fischer B; Pinho JRR; Lemos JAR; Oliveira-Filho AB
    Arch Virol; 2018 Mar; 163(3):617-622. PubMed ID: 29164400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon.
    Oliveira-Filho AB; Sawada L; Pinto LC; Locks D; Bahia SL; Castro JA; Hermes RB; Brasil-Costa I; Amaral CE; Lemos JA
    Virol J; 2014 Feb; 11():38. PubMed ID: 24564954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
    Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
    Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
    Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
    J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of hepatitis C virus genotypes among intravenous drug users. A ten-year study in Palermo, Sicily.
    Vitale F; Villafrate MR; Viviano E; Perna AM; Bonura F; Di Benedetto MA; Mazzola G; Colletti P; Prestileo T; Romano N
    New Microbiol; 1998 Oct; 21(4):335-42. PubMed ID: 9812314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus (HCV) core serotypes in chronic HCV infection.
    Mondelli MU; Cerino A; Bono F; Cividini A; Maccabruni A; Aricò M; Malfitano A; Barbarini G; Piazza V; Minoli L
    J Clin Microbiol; 1994 Oct; 32(10):2523-7. PubMed ID: 7814491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil.
    Lopes CL; Teles SA; Espírito-Santo MP; Lampe E; Rodrigues FP; Motta-Castro AR; Marinho TA; Reis NR; Silva AM; Martins RM
    Rev Saude Publica; 2009 Aug; 43 Suppl 1():43-50. PubMed ID: 19669064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.